On 20 November, members of the EPAD WP6 communication team held a one day meeting in Amsterdam to update the communication plan for the final two years of the project.…
On 3rd November, we presented the first analysis of the EPAD data at CTAD (Clinical Trials on Alzheimer’s Disease) in Boston, USA. This analysis was primarily illustrative as did…
What is your current role in EPAD? I wear two hats within EPAD. Firstly I work for WP3, which is led by Pieter Jelle Visser at VUmc and Gerald Luscan…
What is your current role in EPAD? I am a member of the Executive committee, the CDEx clinical Mitterrand and balancing committee. What did you do prior to joining…
On 18-19 October, IMI organised its Stakeholder Forum 2017 in Brussels under the theme ‘Open innovation’. On the first day of the event, IMI was looked through the lens of…
On 16-18 October, the European Prevention of Alzheimer’s dementia (EPAD) project organised its first IMI-AD Platform Disease Modelling Workshop in Edinburgh, UK. The aim of the meeting was to bring…
A great occasion to get to know more on three Alzheimer’s Disease IMI (Innovative Medicines Initiative) projects, was at the 27th Alzheimer Europe Conference (#27AEC), held in Berlin from 2-4…
In September 2017, two articles about the EPAD project appeared in the media. On 19 September, the Italian newspaper “la Repubblica” published an article entitled “L’Alzheimer si combatte giocando d’anticipo”…
The EPAD family bids a fond farewell to Lennert Steukers. Lennert worked full time as project manager for Janssen on the IMI-EPAD project and provided the overall management to the…
The EPAD project reached the halfway of the project in June 2017. Given that all IMI projects are subject to an official Mid Term Review, EPAD held its IMI Mid-Term…
